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Review
There is a growing interest in advancing our 
understanding of environmental exposures that 
influence the development of disease. Asthma is 
a complex and heterogeneous syndrome, with 
a variable phenotype characterized by chronic 
airway inflammation, reversible airflow limita-
tion, airway hyperreactivity, and excess mucous 
secretion (Bosse and Hudson 2007; von Mutius 
2008). Multiple genes have been associated with 
the development of asthma (Ober and Hoffjan 
2006), as have numerous exposures (Miller and 
Ho 2008) [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002267)].
The environment clearly influences the 
development of allergies and asthma, because 
having a particular gene or combination of 
genes does not guarantee the development of 
these conditions. Occupational asthma like-
wise points toward the role of environment in 
disease development (Bernstein et al. 2006), 
as do the changes in asthma prevalence in the 
past 30–40 years (Platts-Mills et al. 2005; von 
Mutius 1998) .
Gene and environment interactions are 
also suspected in asthma and allergies (Hunter 
2005), as are epigenetic mechanisms (Baccarelli 
et al. 2009; Nawrot and Adcock 2009). 
However, knowledge about how environmental 
exposures participate in epigenetic mechanisms 
is in its infancy (Baccarelli et al. 2009; Miller 
and Ho 2008; Nawrot and Adcock 2009).
Longitudinal cohort studies are the most 
powerful observational study design for study-
ing exposure–response relationships pertain-
ing to disease development. Because of the 
relatively long observation period for cohort 
studies, it is also possible to undertake inter-
vention studies to investigate selective avoid-
ance and disease outcomes (Clayton and 
McKeigue 2001). Examples of this approach 
can be found in the Prevention and Incidence 
of Asthma and Mite Allergy study (PIAMA) 
(Brunekreef et al. 2002) as well as the 
Canadian Allergy Primary Prevention Study 
(CAPPS) (Becker et al. 2004).
Cohort studies have drawbacks: They are 
expensive and time consuming, and investiga-
tors must carefully plan the exposure assess-
ment component (Rothman and Greenland 
1998). Researchers must think critically about 
what can be measured, when to measure it, 
and the associated costs, because improved 
exposure assessment will lead to decreased 
measurement error and significantly increased 
study power (Armstrong 1996; London 2007; 
Wong et al. 2003).
Knowledge about which environmental 
exposures and behaviors confer risk is impor-
tant because many environmental exposures are 
modifiable and thus preventable. Understanding 
the biological mechanisms that underlie the 
development of disease is necessary for the 
design of effective environmental interventions 
and therapeutics. The identification of causal 
exposures depends on accurate measurement of 
both exposures and outcomes; this is a challenge 
for many reasons, summarized in Supplemental 
Material, Table 2 (doi:10.1289/ehp.1002267).
Quantifying environmental exposures in 
cohort studies is complex and involves diffi-
cult decisions, including tradeoffs in the short 
and long term. Researchers designing cohort 
studies of childhood asthma must prioritize 
their research questions and refine exposure 
assessment strategy to ensure that their study 
makes a meaningful contribution.
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Ba c k g r o u n d: The environment is suspected to play an important role in the development of 
  childhood asthma. Cohort studies are a powerful observational design for studying exposure–  response 
relationships, but their power depends in part upon the accuracy of the exposure assessment.
oB j e c t i v e: The purpose of this paper is to summarize and discuss issues that make accurate expo-
sure assessment a challenge and to suggest strategies for improving exposure assessment in longitu-
dinal cohort studies of childhood asthma and allergies.
da t a synthesis: Exposures of interest need to be prioritized, because a single study cannot measure 
all potentially relevant exposures. Hypotheses need to be based on proposed mechanisms, critical 
time windows for effects, prior knowledge of physical, physiologic, and immunologic development, 
as well as genetic pathways potentially influenced by the exposures. Modifiable exposures are most 
important from the public health perspective. Given the interest in evaluating gene–environment 
interactions, large cohort sizes are required, and planning for data pooling across independent stud-
ies is critical. Collection of additional samples, possibly through subject participation, will permit 
secondary analyses. Models combining air quality, environmental, and dose data provide exposure 
estimates across large cohorts but can still be improved.
co n c l u s i o n s: Exposure is best characterized through a combination of information sources. 
Improving exposure assessment is critical for reducing measurement error and increasing power, which 
increase confidence in characterization of children at risk, leading to improved health outcomes.
key w o r d s : childhood asthma, cohort studies, exposure assessment. Environ Health Perspect 
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Objectives
This manuscript was motivated as a result 
of a workshop held in Banff, Canada, 
9–10 February 2008, in connection with 
the launch of the Canadian Healthy Infant 
Longitudinal Development (CHILD) birth 
cohort (Subbarao et al. 2009). The purpose 
of this review is to discuss the design of envi-
ronmental exposure assessment in longitudinal 
cohort studies of childhood asthma and aller-
gies. This review is not intended to be a system-
atic review of the topics presented, but rather 
a focused discussion of, and a starting point 
for developing, more effective exposure assess-
ment strategies pertaining to the environmental 
causes of asthma and allergy. The references 
cited herein guide readers to more in-depth 
discussions on specific issues raised, whereas this 
review as a whole provides a broader perspec-
tive on decisions that affect the environmental 
exposure data and ultimately the power of the 
cohort study under design. This review thus 
serves as an introduction to the challenges in 
exposure assessment that environmental epide-
miologists continue to face.
Results
Developing an exposure assessment strategy. 
The exposures linked with childhood asthma in 
Table 1 [Supplemental Material (doi:10.1289/
ehp.1002267)] are numerous and include 
those that may act through different uptake 
routes: inhalation, ingestion, and dermal. 
Historically, the research focus has been on 
inhalation, but this is changing, particularly 
with respect to occupational asthma (Redlich 
and Herrick 2008). Relevant exposures include 
biological, chemical, and physiological agents 
that can be encountered in a variety of envi-
ronments including the home, school, and 
outdoors, and those that can start in utero. 
Although not discussed in detail here, parental 
take-home exposures related to their occupa-
tion, or paraoccupational exposures, may also 
play a role in the development of childhood 
asthma (Magnusson et al. 2006). Furthermore, 
as adolescents enter the workforce, they may 
have their own relevant occupational exposures 
(Syamlal and Mazurek 2008).
Three general strategies for characterizing 
environmental exposures include questionnaires, 
environmental samples, and predictive models. 
Measurement of biomarkers of exposure can 
also be used, but they are typically not applied 
in large cohort studies for asthma/allergies and 
therefore are not included in this review.
Questionnaires are a common tool 
for assessing exposure. Questionnaire data 
are typically surrogate measures for the 
exposure(s) of interest. The researcher relies 
on a conceptual model of how the surrogate is 
related to the exposure of interest and of how 
well the surrogate differentiates between dif-
ferent exposure levels.
Information on a variety of exposure 
and exposure scenarios, including inhala-
tion and ingestion of biological and chemical 
agents, can be acquired from questionnaires 
[Supplemental Material, Table 3 (doi:10.1289/
ehp.1002267)]. The main limitation of using 
questionnaires to assess exposure is recall bias 
(Le Moual et al. 2000). There are also limits to 
how much can be asked on a single question-
naire, how frequently it can be administered, 
and how specific it can be made. In addi-
tion, asking subjects about specific exposures 
on questionnaires assumes that the subject 
will recognize both the exposure agents and 
their own exposure. These issues can result 
in the wrong question or too many questions 
being asked, leading to imprecise data, subject 
fatigue, and/or a poor response.
Environmental samples or measurements 
are considered the most precise way to quan-
tify the exposure of an individual at a point 
in time. Many exposures of interest can be 
measured, either directly or through collec-
tion of samples for subsequent analysis, at least 
for a short time period. However, whether 
measurements are practical with respect to 
the cost and the burden on subjects differs by 
exposure. In reality, a single measurement fails 
to describe the variability of an individual’s 
exposure over time, and the quantity of a spe-
cific agent measured in a child’s environment 
is, at best, a surrogate for dose.
Before deciding to undertake exposure 
measurements, researchers should consider 
whether a reliable and validated surrogate 
could be obtained more easily. Of particular 
importance is the type of data that will be gen-
erated from an environmental measurement 
versus a questionnaire. In some cases an expo-
sure measurement may be unnecessary. For 
example, the presence of pets can be ascer-
tained from questionnaires or from observa-
tion. But to determine the exposure–response 
relationship between pet dander and asthma 
symptoms, a measurement of cat dander in 
house dust is more desirable, because many 
houses without a furry pet have measurable lev-
els of dander (Chew et al. 1998; Gehring et al. 
2004; Nafstad et al. 2001). Similarly, recent 
research on thirdhand smoking indicates that 
residual tobacco smoke contamination remains 
after the cigarette is extinguished (Winickoff 
et al. 2009). Although exposures related to 
first- and secondhand smoking are believed to 
be assessed reliably through questionnaires, this 
additional route for tobacco product exposure 
may require modification to questionnaires or 
more emphasis on measurements (i.e., air sam-
pling or urine cotinine) to develop sufficiently 
informative exposure measures.
In studies of the environment and child-
hood asthma, the exposures that tend to be 
measured quantitatively are indoor dust, house 
dust mite allergens, pet allergens, indoor air 
pollutants, and outdoor air pollutants. Many 
birth cohorts focusing on environmental deter-
minants of childhood asthma and allergies have 
measured and reported these exposures at mul-
tiple time points and locations within the child’s 
environment. Table 1 summarizes the expo-
sure assessment in a selection of large cohorts 
that focused on the development of childhood 
asthma in relation to environmental exposures 
other than air pollution. Table 1 highlights not 
only the similarities in exposures selected for 
measurement, but also the differences in timing 
and location of sample collection. These differ-
ences between studies complicate interpretation 
and comparison of results as well as subsequent 
data-pooling efforts.
The reliability of exposure measurements is 
limited by several factors, including the choice 
of exposure measured, how it relates to the 
relevant dose and/or biological pathway, and 
the method used to collect and analyze the 
sample, as well as the uncharacterized variabil-
ity in exposure over time and place. Each will 
contribute to the overall error and variability 
of the measured value.
Investigators rarely, if ever, measure the 
actual exposure that an individual receives; 
ultimately, exposures are quantified based on 
surrogate information and a model (or a combi-
nation of models) that link this information to 
exposure based on common assumptions. The 
model can be simple, such as the presence of a 
furry pet equals exposure to dander, or more 
complex—using monitoring data for assigning 
air pollution exposure. In both cases, surrogates 
are measured, and an underlying model relates 
the surrogate to the exposure of interest.
Estimating exposure using models: an air 
pollution example. In previous cohort studies of 
air pollution and childhood asthma, indicator 
variables or interpolation methods have been 
used to assign exposure based on a single piece 
of information [i.e., distance to major roads 
(Brunekreef et al. 1997)]. In recent years, com-
plex modeling approaches have become com-
mon for assigning exposure. Approaches for 
modeling air pollutants vary; some use emis-
sions or monitoring data as inputs, whereas 
others use measurements collected explicitly for 
the purposes of constructing the model (Brauer 
et al. 2003).
Land-use regression (LUR) models relate 
measurement data at multiple sites with readily 
available spatial information (from geographic 
information systems, such as road and pollut-
ant emission location, to calculate air concen-
trations (i.e., estimated exposures) across an 
unsampled area with high resolution (50 m 
or better) (Brauer et al. 2003; Hoek et al. 
2008). Regional-scale air quality models, such 
as the grid-based Community Multiscale Air 
Quality (CMAQ), use emissions and meteo-
rologic inputs combined with knowledge on 
atmospheric chemistry, thermodynamics, and Exposure assessment and childhood asthma
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physics to provide temporally resolved predic-
tions across large spatial areas (~ 1 × 1 km and 
larger grids) (Byun and Schere 2006). Local-
scale air dispersion models (e.g., AERMOD) 
use emissions data to estimate local concen-
trations with smaller-scale spatial variability 
(Cimorelli et al. 2005). Unlike the regional-
scale models, these do not incorporate detailed 
atmospheric chemical reactions, and meteoro-
logical information (e.g., wind direction and 
speed) is rarely available for all the locations of 
interest. Combining grid-based regional-scale 
Table 1. Summary of exposure assessment in some previous birth cohort studies of asthma and allergies in children that did not focus exclusively on air pollution. 
Cohort (references) Year(s) Type Exposures Sample type Sample location Timing of measurement
CaPPS (Canadian 
Asthma Primary 
Prevention Study) 
(Canada) (Becker et al. 
1999, 2004; Carlsten 
et al. 2009)
1995
 
C, I, HR HDM, cat (µg/g dust) Dust Bedroom floor (child, parent), 
mattress (child, parent), living 
room floor, furniture
Before birth, 2 weeks, 
4 months, 8 months, 
12 months, 18 months, 
2 years, 7 years
Dog (µg/g dust) Dust 1 year, 2 years, 7 years
ETS (ng/mg creatinine) Biomarker Urine (cotinine) 2 weeks
ETS (ng/mg creatinine) Biomarker Breast milk (cotinine) 4 weeks
Outdoor air pollution (NO, NO2, 
PM2.5, black carbon – µg /m3)
LUR model Home address 1 year, 7 years
BAMSE (Sweden) 
(Almqvist et al. 2003; 
Emenius et al. 2003, 
2004; Wickman et al. 
2002)
1994–1996 C Air change rate (changes 
per hour)
Measurement, passive 
tracer gas
All rooms First winter season after 
birth
Temperature (°F and °C) Measurement Living room and bedroom (child)
RH (g/kg) Measurement Living room and bedroom (child)
Indoor NO2 (µg/m3) Air, passive sampler Living room, outside living room 
window
Cat, dog (µg/m3 dust) Dust, vacuum Mattress (parent) 2 months
Outdoor NO2 (µg/m3 dust) Dispersion model using 
emission data
Home address(es) First year of life
MAS (Multicentre 
Allergy Study) 
(Germany) (Lau et al. 
2000, 2005; Nickel 
et al. 2002)
1990 C, HR HDM, cat (ng/g dust) Dust, vacuum Living room, bedroom (child, 
parent)
6 months, 18 months, 
3 years, 4 years, 5 years, 
7 years
  HDM, cat (ng/g dust) Dust, vacuum Mattress 5 years, 10 years
  Endotoxin (EU/mg dust) Dust Mattress 10 years
PIAMA (Prevention 
and Incidence of 
Asthma and Mite 
Allergy) (Netherlands) 
(Brunekreef et al. 
2000; Gehring et al. 
2009; van Strien et al. 
2000, 2002)
1996–1997 C, I, HR HDM (ng/m2), cat (mU/m2), dog 
(dog ng/m2)
Dust, vacuum Mattress (child, parent), living 
room floor
3 months, 4 years, 
6 years, 8 years
LPS (U/mg), EPS (U/mg), 
β-glucans (g/mg dust)
Dust, vacuum Mattress (child), living room floor 3 months
ETS (µg/m3) Air (nicotine) Home 2-week samples, 
1997–1998
Outdoor air pollution [PM2.5 
(µg/m3), NO2 (µg/m3), soot 
(10–5 m–1)] 
LUR model Address at birth Long-term average
MAAS (Manchester 
Asthma and Allergy 
Study) (United 
Kingdom) (Custovic 
et al. 2000)
1995–1997 C, I HDM (ng/m2 and µg/g dust) Dust, vacuum Bed (child, parent), bedroom floor 
(child, parent), living room floor, 
furniture
Week 10 of pregnancy, 
birth, 6 months, 1 year
Boston, MA (USA) 
(Chew et al. 1998; 
Gold et al. 1999)
1994–1996 C, HR HDM (µg/g), cat (µg/g), 
cockroach (µg/g)
Dust, vacuum Bedroom floor (child), bed (child, 
parent), kitchen floor, chair/sofa
2–3 months
Temperature (°C) and RH 
(absolute g/kg, relative %)
Measurement Bedroom floor (child) 2–3 months
British (United 
Kingdom) (Arshad 
et al. 1992)
1990–1991 C, I HDM (µg/g dust) Dust, vacuum Bedroom (child), living room floor, 
furniture
Birth, 3 months, 6 months, 
9 months
PREVASC (Prevention 
of Asthma in Children) 
(Netherlands) 
(Kuiper et al. 2005; 
Schonberger et al. 
2005a, 2005b)
1997–2002 C, I HDM, cat, dog (ng/g dust and 
ng/m2)
Dust, vacuum Mattress (child, parent), LR floor 3–5 months, 7–9 months, 
4 years
RH (NR) Measurement Bedroom (child, parent) Months 3–5 and 7–8 of 
pregnancy, 4 weeks, 
7–9 months, 1 year, 
2 years, 4 years
ETS (NR) Biomarker Exhaled carbon monoxide
Krakow (Poland) 
(Jedrychowski et al. 
2009)
2000–2003 C ETS (ng/mL) Biomarker Cord blood (cotinine) At birth
Detroit, MI (USA) 
(Ownby et al. 2002; 
Peterson et al. 1997, 
1999)
1987–1989 C ETS (ng cotinine/mg creatinine) Biomarker Urine (cotinine) Every 2 months after birth 
for 2 years
HDM (µg/g dust), cat (mU/g dust) Dust, vacuum Beside bed (child) 2 years
HDM (µg/g dust), cat (mU/g dust) Air Bedroom (child) 2 years
Oslo (Norway) (Magnus 
et al. 1998; Nafstad 
et al. 1998)
1992–1993 C, CC NO2 (µg/m3) Air, passive sampler Breathing zone (child); area: 
bedroom (child), kitchen wall, living 
room, child care, outside of house
During first 2 years of 
life, after meeting case/
control definition
HDM (count per bed) Dust, vacuum Mattress (child)
RH (g/kg) Measurement Living room
Air change rate (changes per 
hour)
Measurement, passive 
tracer gas
Whole home
Abbreviations: C, cohort; CC, case control; EPS, extracellular polysaccharides (specifically from genera Penicillium and Aspergillus in PIAMA cohort); ETS, environmental tobacco 
smoke; HDM, house dust mites; HR, high risk; I, intervention; LPS, lipopolysaccharide; NR, not reported; RH, relative humidity.Arrandale et al.
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and local-scale dispersion models is a current 
area of development to improve air quality 
modeling for exposure estimation.
A major limitation of outdoor air pollu-
tion information (modeled or measured) is 
that it does not account for the majority of 
time people spend indoors (Ozkaynak et al. 
2008). Additional models, which combine 
air quality models and/or measurements with 
exposure models [Hazardous Air Pollutant 
Exposure Model (HAPEM)] and dose mod-
els [Stochastic Human Exposure and Dose 
Simulation (SHEDS)], are available. For exam-
ple, SHEDS estimates time–activity patterns as 
well as microenvironment exposure differences 
for populations based on census data and time–
activity studies (Burke et al. 2001; Isakov et al. 
2009; Ozkaynak et al. 2009). Models can also 
be combined with time–activity information so 
that the movement of a subject over the course 
of the day and the resulting variation in expo-
sure between outdoor microenvironments is 
accounted for (Nethery et al. 2009; Ryan et al. 
2008). To apply these approaches to a cohort 
study requires subject-specific time–activity 
information, which is difficult to obtain for 
long time periods and thus tends to rely on 
snapshots of information from questionnaires.
The amount of detail and temporal resolu-
tion that can be obtained regarding exposure 
over the course of a cohort study is limited. It 
is impossible to evaluate all exposures continu-
ously, and there are limitations to the meas-
urement collection. Environmental exposure 
measures are usually time-averaged environ-
mental concentrations relevant to the external 
exposure of the agent rather then the inter-
nal, or absorbed, dose. Furthermore, for some 
agents, cost-effective sampling and analytical 
methods are not available. For others it is a 
struggle to convert questionnaire responses 
into meaningful exposure metrics because of 
limited validation information.
Prioritizing exposure assessment. There are 
too many exposures associated, or hypothe-
sized to be associated, with childhood asthma 
to evaluate them all in a single study. Given 
limited resources, there are tradeoffs between 
number of exposures to explore and the accu-
racy and resolution with which they can be 
characterized. Additionally, no single exposure 
is likely to hold the key to childhood asthma 
[i.e., mono-interventions are ineffective (Maas 
et al. 2009)], and new hypotheses about envi-
ronmental exposures will evolve over the course 
of a cohort study.
How should exposures be prioritized in the 
context of cohort studies? How many exposures 
should be studied? At what time point(s) or life 
stage will exposure be measured? How often 
within each life stage will exposure be meas-
ured? Will the exposure be constant or vary over 
the exposure window of interest? Can expo-
sures with similar mechanisms be combined 
in analyses? These questions are critical to the 
design of a rigorous exposure assessment strat-
egy. Examples of some general strategies that 
could help prioritize the exposures of interest 
in a cohort study are importance for public 
health, existing measurement capability, biolog-
ical mechanisms, and potential for future data 
pooling. This list is not exhaustive, nor would 
strategies need to be employed exclusively.
When considering the public health impor-
tance of an exposure, priority should be given 
to exposures that are modifiable and prevalent 
in the population and have been hypothesized 
to be associated with development of asthma. 
Under this scheme, exposures of priority might 
be environmental tobacco smoke, building 
moisture levels, microflora related to building 
moisture, air pollution, and pest allergens (e.g. 
mite, cockroach, rodent). Exposures of second-
ary priority under this scheme might include 
those that are not easily or justifiably modifi-
able (e.g., pollen) as well as exposures that are 
highly speculative (e.g., diet, gut microflora, 
and phthalates). Modifiable exposures could 
occur at many levels, from the individual level 
(e.g., smoking) to the policy level (e.g., local 
policy on smoking in public areas, or national 
policy on air pollutants). The ability to reliably 
characterize the exposures of interest is a critical 
consideration when prioritizing exposures. The 
existence of a validated measurement method 
often influences the allocation of resources nec-
essary to collect the desired data. In the case 
of ambient air pollutants, if a model has been 
developed for the study area, its application to 
derive exposure estimates for study participants 
is straight forward and low cost. However, if 
this model has not been developed, another 
method of estimating exposure may be more 
practical. Similarly, the validity and reliabil-
ity of questionnaire items should also be con-
sidered if self-reported exposure data are to 
be collected. The validity and reliability of 
new questionnaire items can always be tested 
in a subset of participants, but this requires 
resources and could delay progress.
It is important to maximize the amount of 
information that can be retrieved from a single 
sample. Both dust samples and questionnaires 
can provide a significant amount of informa-
tion on multiple exposures from a single sam-
ple. Dust samples provide the opportunity 
for quantifying exposure to a variety of agents 
(e.g., allergens, phthalates, and fungal mark-
ers) and when collected from a reservoir, such 
as deep carpet, can represent a time-integrated 
exposure (Roberts et al. 2009). Previous stud-
ies have also demonstrated that it is possible to 
have subjects participate in the collection of 
dust samples, making it more cost effective to 
collect multiple samples over time (Arbes et al. 
2005; Schram-Bijkerk et al. 2006).
The biological mechanism of action can 
also be used as a method for prioritizing 
exposures. This can be conceptualized in two 
ways. First, exposures that act through the 
same biological pathway as other exposures that 
have been associated with asthma may be high 
priority for further study. Alternatively, if sev-
eral exposures act through the same biological 
pathway, methods for quantifying biomarkers 
of exposure (or effect) within the pathway can 
be developed to measure dysfunction in the 
pathway. This dysfunction can then be related 
to the outcome or the exposure of interest, 
reducing exposure assessment costs.
Both of these approaches require the iden-
tification of pathways and mechanisms relevant 
to childhood asthma. We suggest five pathways, 
as a starting point, through which exposures 
could act to ultimately cause childhood asthma:
•	Oxidative	stress	(Bhalla	et	al.	2009;	
Ciencewicki et al. 2008; MacNee 2001; 
Yang et al. 2008)
•	Disruption	of	epithelial	barrier	function	
(Bhalla et al. 2009; Hammad and Lambrecht 
2008; Holgate 2008; Knight and Holgate 
2003)
•	Adaptive	versus	innate	immune	response	
(Bhalla et al. 2009; Hammad and Lambrecht 
2008)
•	Disruption	of	normal	airway	development	
or later airway remodeling (Becklake and 
Kauffmann 1999; Folli et al. 2008; Postma 
2007)
•	Genetic	and	epigenetic	inheritance	(Bosse	
and Hudson 2007; Moffatt 2008; Ober and 
Hoffjan 2006; Yang et al. 2008).
These pathways are not mutually exclusive; 
often exposures (genetic or environmental) act 
through multiple pathways simultaneously, 
and pathways may also interact to cause detri-
mental effects in the lung (i.e., genetic control 
of immune response).
Interest in gene–environment interactions 
has created a need for studies with large sam-
ple sizes. Obtaining sufficient power to find a 
significant interaction is unlikely in any one 
cohort (because of small sample size) but is 
more likely with a meta-analysis or pooled 
analysis of multiple cohorts (Hunter 2005). 
These approaches could be particularly useful 
in genomewide association studies (GWAS) 
(Zeggini and Ioannidis 2009).
To successfully pool data across studies, it 
is ideal to plan for data pooling during study 
design. Ideally the exposure assessment strat-
egy should be the same across all studies to be 
pooled. In reality, this means the same expo-
sures are measured at the same time points 
using the same methods/protocols, which is 
difficult to achieve. To the extent that it is 
scientifically justified, new studies should con-
sider harmonizing some target exposures with 
existing studies.
Power for a gene-by-environment study 
depends on four factors: the true effect size, the 
exposure prevalence, the genotype prevalence, Exposure assessment and childhood asthma
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and measurement error (Wong et al. 2003). It 
is not possible to manipulate exposure preva-
lence or genotype prevalence, but measure-
ment error can be directly influenced by study 
design (Vineis 2004; Wong et al. 2003).
Measurement error can be reduced 
through refined research questions, accurate 
genotyping, improved understanding of the 
mechanism of effect, repeated measurements 
of exposure, and improved timing of expo-
sure measurements (Vineis 2004; Wong et al. 
2003). Improved exposure assessment will lead 
to more precise exposure estimates as well as 
decreased measurement error and significantly 
increased study power (Armstrong 1996; 
London 2007; Wong et al. 2003).
Timing and duration of exposure meas­
ures. Questions about when, where, and how 
often to measure exposure are inherent in 
each of the prioritization schemes presented. 
Environmental exposures are likely to change 
over time and over space; thus, repeated meas-
urements of exposure are desired. In this case, 
the timing, location, and duration of each 
sample within the life course and the micro-
environments occupied by the subject will 
have to be determined.
It is crucial to consider the biologically rel-
evant time scales of exposure. Is the exposure 
of interest short and intense or longer term and 
cumulative? And when is the relevant expo-
sure period (window of susceptibility) in the 
continuum of development? Beyond this, the 
physicochemical properties of the exposure and 
the toxicokinetics must be considered. If bio-
markers of exposure are being measured, then 
the relevant metabolites and half-life of the 
compound within the body must be known 
so that samples are collected at times that will 
accurately assess the exposure period of inter-
est. If these values are unknown in humans, 
extrapolation from animal studies may be 
necessary, while recognizing that the dose and 
route of exposure in animal studies may not be 
the same for human environmental exposures.
In the case of studies on the development 
of childhood asthma, the outcome is a chronic 
(but in some cases transient or recurrent) dis-
ease. Depending on the exposure, we may be 
interested in either short-term peak exposures 
or in long-term chronic exposures occur-
ring in the prenatal, perinatal, or postnatal 
period. Increased understanding of mecha-
nisms, gene–environment interactions, and 
critical windows of exposure will facilitate 
decisions regarding the specific exposures and 
approaches for assessment.
Determination of the correct time to 
measure exposure is often impossible with the 
current state of knowledge. Information gener-
ated by birth cohort studies, including mecha-
nisms of effect, may help determine when 
important windows of exposure occur. The 
need for plausible biological mechanisms must 
be highlighted. The biological target of the 
exposure must be considered, and the relevant 
developmental trajectory of the target organ or 
system must be at least partially understood. 
Without this knowledge, sample collection is 
more likely to be haphazard.
Environmental exposures from conception 
through the prenatal and perinatal periods and 
into childhood have been linked to the devel-
opment of childhood asthma; thus the deci-
sion on when to measure exposure is difficult. 
Environmental exposures during pregnancy 
are important, but exposures during the first 
and second year of life are currently considered 
to be the most important (Dietert and Zelikoff 
2008; Holt and Jones 2000; Peden 2000). 
This perspective may change as understand-
ing of how epigenetic mechanisms impact the 
development of asthma deepens.
In relation to asthma, the development of 
both the respiratory and immune systems is 
relevant. These systems begin to develop in the 
early prenatal period and continue through 
the perinatal and postnatal periods (Becklake 
and Kauffmann 1999; Dietert and Zelikoff 
2008; Holt and Jones 2000; Peden 2000; 
Pinkerton and Joad 2000; Pirruccello et al. 
1989). It is possible that there are multiple 
windows of exposure, which may necessitate 
collection of multiple samples over the course 
of development. Further complicating this is 
the interaction between some exposures, such 
as endotoxin, and immune system develop-
ment. This may mean that for the same com-
pound there may be a window of protection 
as well as susceptibility in asthma (von Mutius 
2007; von Mutius and Radon 2008).
Methodologic advances in exposure assess­
ment. Individuals are exposed to many xeno-
biotic substances in the course of daily life. 
The challenge for epidemiology is to separate 
the effects of different exposures and the con-
tribution of one’s genetic profile.
One potential strategy to overcome these 
challenges is to assign exposure profiles to an 
individual based on their exposure to a com-
bination of agents. First, a group of exposures 
(the exposure profile) is linked to the out-
come; the next step determines which of the 
exposures in the profile is dominant. This is 
similar to risk stratification strategies in cardio-
vascular and other chronic diseases (Cannon 
and Greenberg 2008; Sabir et al. 2008). We 
often use composite exposures such as envi-
ronmental tobacco smoke and traffic pollution 
to define complex mixtures. The agents that 
make up these mixtures are highly correlated, 
and it often makes more sense to use them as 
a composite rather than a set of separate but 
related exposures. This is similar to many risk 
factors for asthma that can be highly correlated 
in some populations.
In 2005, Wild published an editorial 
encouraging the development of an exposome 
to complement the genome (Wild 2005). The 
exposome would “encompass life course envi-
ronmental exposures (including lifestyle factors) 
from the prenatal period onwards” and would 
evolve over the life course. The characteriza-
tion of the exposome of an individual would 
be dependent on biomarkers (of exposure 
and/or effect) as well as improved questionnaire-
based methods for assessing exposure. Detailed 
charac  terization of exposomes and subsequent 
linkage to different asthma phenotypes would 
theoretically aid in identification of groups of 
genes responsive to an exposure and groups of 
exposures that act through common pathways. 
Clearly, a considerable amount of detailed expo-
sure data on large numbers of individuals would 
need to be compiled to begin to assess the extent 
to which a manageable number of unique expo-
somes exists. Optimally, such an effort should 
take place within the context of a cohort. In the 
long term, this approach may facilitate exposure 
profiling, leading to more effective and targeted 
preventative measures or treatments.
To sample exposure more frequently at 
minimal cost, participants can be engaged 
in data collection. This technique has been 
demonstrated using vacuum socks (Schram-
Bijkerk et al. 2006), electrostatic wipes (Arbes 
et al. 2005; Cozen et al. 2008; Schram-Bijkerk 
et al. 2006), and passive samplers (Johnson 
et al. 2009). New methods for exposure 
measurement by subjects have also been 
proposed (Karlsson et al. 2002; Noss et al. 
2008; Sercombe et al. 2005). However, there 
is a limit to subject participation in collect-
ing exposure samples; subjects are unlikely to 
undertake a complicated or time-consuming 
protocol, and ethical issues surrounding sub-
ject burden may also need to be addressed.
The collection of additional samples, or 
additional sample volume for archiving, per-
mits the future study of hypotheses that were 
not feasible or not yet relevant during the 
cohort planning stages. Often these analyses 
will take the form of nested case–control stud-
ies within the larger cohort. The collection of 
additional samples requires storage methods 
that preserve the integrity of samples over the 
entire storage period. The maximum dura-
tion of storage and ideal storage environment 
will depend on the type of sample (e.g., dust, 
blood) as well as the analyte of interest (e.g., 
endotoxin, hormones) (Douwes et al. 1995; 
Holl et al. 2008; Macher 2001).
Ethical considerations. In addition to the 
ethical considerations inherent in all cohort 
studies, when exposure measurements are made 
in private residences, the findings can have seri-
ous implications for property values and occu-
pant health. In the case of critical problems, 
there is responsibility to report the issue to the 
relevant authority immediately (i.e., child abuse 
or neglect). More generally, there is a duty to 
report back to the homeowner the findings of Arrandale et al.
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the investigation (Lambert et al. 2003; Paulson 
2006). The homeowner has the right to under-
stand the meaning of the results and how they 
affect both the occupants and the structure 
itself. For these reasons it is important to have 
a plan to communicate results to participants 
in a meaningful way. This could include both 
visual and written interpretations of the results, 
and the summary could be generic for each 
quartile (for example) of the data rather than 
specific to each home.
Conclusions
Ideally, environmental samples would be 
obtained using accurate and precise methods 
during the relevant windows of exposure and 
processed appropriately to permit prompt 
analy  sis for existing hypotheses and the pursuit 
of additional research questions in the future. 
In reality, decisions are made based on available 
resources, the research interest of the individual 
researchers, and priorities of the funding orga-
nizations. A single study cannot do everything. 
Recognizing these limitations, there remains a 
significant need for better exposure assessment 
in epidemiological studies.
Exposure levels will vary between indi-
viduals and also over time and space within 
individuals. We must gain more knowledge 
of the biological mechanisms underlying dis-
ease to properly identify the windows of expo-
sure, the relevant duration of exposure, and 
possible latency period(s). Multiple measures 
of exposure must be collected where pos-
sible. Modeling of exposures as well as subject 
partici  pation in data collection may ease the 
burden of measuring exposure more frequently, 
but both require evaluation.
Researchers have to make decisions about 
what to measure, which microenvironment to 
measure in, where exactly to measure within 
each microenvironment, which methods to 
employ, and at what time point(s) to meas-
ure. These decisions involve tradeoffs between 
the accuracy and precision of exposure meas-
ures, the completeness of the exposure assess-
ment, and the statistical power of the study, as 
well as the resources available and burden that 
will be placed on participants. Hypotheses 
about relevant exposures need to be based on 
knowledge of biological mechanisms, gene–
environment interactions, and physiological 
development. Exposures of interest can be pri-
oritized based on many levels, including pub-
lic health importance, measurement ability, 
biological mechanism of action, and the future 
use of the data collected.
Gene–environment interaction studies are 
an area of immense research interest but are at 
even higher risk of being underpowered. Better 
exposure assessment and more precise pheno-
type ascertainment are the most efficient ways to 
increase the power in such studies. Secondarily, 
data pooling can also increase power, permit 
analyses not possible with smaller sample sizes, 
and increase the probability of replicable results.
Additionally, there is a need to consider 
data compatibility across cohorts when design-
ing a new study. Exposures should be priori-
tized not only on the goals of the individual 
study but also on the power that may result 
from pooling data from multiple studies.
Summary
Several areas of exposure assessment can be 
targeted for immediate improvement in stud-
ies of childhood asthma:
•	Planning	for	data	pooling,	as	well	as	storage	
of samples for future analyses, at the outset 
of cohort studies;
•	Refining	the	exposure	assessment	protocol,	
questionnaires, and/or measurements to 
account for relevant time periods of exposure;
•	Engaging	participants	in	the	measurement	
of exposure to permit the collection of mul-
tiple samples over the course of the study;
•	Increased	use	of	hybrid	methodologies	that	
combine pollutant data with atmospheric fate 
and transport, exposure, and dose models.
Ultimately, exposure is best characterized 
through a combination of information sources, 
and future studies should strive to improve 
their exposure-assessment strategy. Collectively, 
this information may yield unique exposure 
profiles common among subsets of the popula-
tion that will help characterize children at risk 
and improve health outcomes.
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